Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …

Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Background The role of direct oral anticoagulants as compared with vitamin K antagonists
for atrial fibrillation after successful transcatheter aortic-valve replacement (TAVR) has not …

Aims The respective roles of oral anticoagulation or antiplatelet therapy following
transcatheter aortic valve implantation (TAVI) remain debated. ATLANTIS is an international …

Background The effect of single as compared with dual antiplatelet treatment on bleeding
and thromboembolic events after transcatheter aortic-valve implantation (TAVI) in patients …

This meta-analysis and systematic review was performed to evaluate the clinical relevance
of subclinical leaflet thrombosis (SLT) following transcatheter aortic valve replacement …

Background Pivotal trials of percutaneous left atrial appendage occlusion (LAAO) used
specific postprocedure treatment protocols. Objectives This study sought to evaluate …

Background: It is unknown whether the direct oral anticoagulant edoxaban can reduce
leaflet thrombosis and the accompanying cerebral thromboembolic risk after transcatheter …

Transcatheter aortic valve implantation (TAVI) is effective in older patients with symptomatic
severe aortic stenosis, while the indication has recently broadened to younger patients at …